Inositol Use in Pregnancy for PCOS

Safety and Efficacy

The American College of Obstetricians and Gynecologists (ACOG) does not specifically mention inositol in their guidelines for PCOS management during pregnancy 1, 2

Metformin appears to be safe during pregnancy according to ACOG guidelines, though documentation on its effects in early pregnancy is limited 1, 2
Weight management is a cornerstone of PCOS treatment, with even modest weight loss of 5% improving both metabolic and reproductive abnormalities 1, 3
For pruritus related to cholestasis that may occur during pregnancy, treatments like cholestyramine, rifampin, or S-adenosyl-L-methionine (SAMe) may be used 4

Consider transitioning to treatments with more established safety profiles in pregnancy if concerned 1, 4
Focus on appropriate weight management during pregnancy 1, 3
Monitor for pregnancy complications that occur at higher rates in women with PCOS 4
Consider vitamin K monitoring if cholestasis develops during pregnancy 4

Avoid combining inositol with other insulin-sensitizing agents during pregnancy without medical supervision 1
Be aware that pregnancy itself may alter PCOS symptoms and medication requirements 4

The American College of Obstetricians and Gynecologists (ACOG) recommends weight loss and exercise as the first-line approach to improve insulin sensitivity, ovulation rates, and metabolic outcomes in PCOS patients 5, 6
ACOG suggests pharmacologic insulin sensitizers, such as metformin and thiazolidinediones, with metformin having a better weight profile and appearing safe in pregnancy 5, 7
For ovulation induction, ACOG recommends clomiphene citrate as the first-line agent, with an 80% ovulation rate and 50% conception rate among ovulators 6

For women not attempting conception, ACOG recommends lifestyle modification first, targeting a 5-10% weight loss through diet and exercise, and considering metformin for improving insulin sensitivity 5, 6, 7
For women attempting conception, ACOG suggests starting with lifestyle modification and clomiphene citrate, with myo-inositol as a potential adjunctive treatment 6